M-CSF SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF

摘要

M-CSF-specific RXl -based or RX-I derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in or remodeling in a subject afflicted with an osteoblastic or osteolytic disease.